BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 7214860)

  • 1. [Clinical and experimental evaluation of the use of eburnamonine in acute anc chronic cerebro-vascular insufficiency].
    Rampello L; Barbagallo G; Costanzo E; Sciacca A; Russo S
    Clin Ter; 1981 Feb; 96(4):371-81. PubMed ID: 7214860
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical evaluation of (-) eburnamonine in chronic cerebrovascular insufficiency].
    De Pergola E; Di Lorenzo L; De Pergola G
    G Clin Med; 1980 Aug; 61(8):628-42. PubMed ID: 7004986
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical, psychological and neurophysiological results of double-blind study on vincamine-cromesilate in patients with cerebro-vascular insufficiency (author's transl)].
    Mikus P
    Arzneimittelforschung; 1978; 28(11):2165-8. PubMed ID: 582924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study of 2 drugs used in the treatment of cerebral vascular insufficiency: I-Eburnamonine and Vincamine].
    Linquette M
    Lille Med; 1978 May; 23(5 Suppl 1):379-81. PubMed ID: 682847
    [No Abstract]   [Full Text] [Related]  

  • 5. [Vincamine in the treatment of minor ictus (due to transient cerebral ischemia)].
    Franzini C; Ferrante P
    Minerva Med; 1974 Apr; 65(29):1631-41. PubMed ID: 4599654
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic approach to TIA and acute cerebral stroke in geriatric patients using a platelet aggregation inhibiting and vasoactive drug].
    Cucinotta D; Monica C; Silvestrini C; Ceccato S; Cocchi C
    G Clin Med; 1979 Apr; 60(4):301-9. PubMed ID: 488589
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical evaluation of treatment with Vincimax in 60 cases of cerebral circulatory insufficiency].
    Desruelles J; Camart JF
    LARC Med; 1981 Dec; 1(3):86-90. PubMed ID: 7349693
    [No Abstract]   [Full Text] [Related]  

  • 8. Cavinton in the treatment of acute stroke.
    Kovács L
    Ther Hung; 1985; 33(1):50-7. PubMed ID: 3841999
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the role of vincamine in the therapy of cerebrovascular diseases and impairment of cerebral function (author's transl)].
    Witzmann HK; Blechacz W
    Arzneimittelforschung; 1977; 27(6a):1238-47. PubMed ID: 332190
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental clinical studies on the effect of eburnamonine in cerebrovascular disorders.
    Jansen W; O'Connolly M; Lehmann E; Mayer M
    Pharmacopsychiatry; 1986 Sep; 19(5):389-94. PubMed ID: 3534902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of initial cerebrovascular insufficiency with vincamine. Polycentric research on 828 cases].
    Minerva Med; 1978 Jun; 69(31):2095-113. PubMed ID: 351463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of the effect of Devincan and Stugeron in patients suffering from cerebrovascular diseases treated at medical departments.
    Udvarhelyi A
    Ther Hung; 1978; 26(1):29-32. PubMed ID: 663872
    [No Abstract]   [Full Text] [Related]  

  • 13. [Multi-center clinical study of the effects of a vasoregulatory-eumetabolic drug (vincamine hydrochloride) on the psychological symptoms of cerebrovascular insufficiency].
    Periti P; Periti G; Colombo Pirola L
    Clin Ter; 1981 Apr; 97(2):137-45. PubMed ID: 7016415
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of circulatory encephalopathy with Cavinton].
    Lebedeva NV; Chukhrova VA; Solov'ev OU; Nepesov RR
    Klin Med (Mosk); 1997; 75(11):51-3. PubMed ID: 9490359
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of cerebrovascular deficiencies. Therapeutic evaluation from 129 cases using the double-blind method against placebo].
    Bargheon J; Durocher AM; Lagrange M
    Sem Hop; 1984 Jan; 60(3):169-74. PubMed ID: 6320441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Controlled clinical study of the effects of Anasclerol in hospitalized patients with cerebrovascular disorders].
    Riccardi T; Passeri F; Locatelli F
    Minerva Med; 1978 Sep; 69(42):2873-8. PubMed ID: 358021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Controlled multicenter clinical studies on the effect of (-)eburnamonine versus placebo in patients with chronic senile cerebral insufficiency of medium significance].
    Aveni-Casucci MA; Canal N; Corsico R; Passeri M; Porro A; Ventura A
    G Clin Med; 1983; 64(9-10):372-94. PubMed ID: 6363189
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effectiveness of using cavinton in patients of different ages with chronic forms of cerebrovascular diseases (clinico-rheographic research)].
    Burtsev EM; Shprakh VV; Savkov VS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(1):39-44. PubMed ID: 3364094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Double-blind study of the therapeutic activity of cerebroxine in the treatment of chronic cerebral circulatory insufficiency].
    Holemans P
    Brux Med; 1979 May; 59(5):279-85. PubMed ID: 380784
    [No Abstract]   [Full Text] [Related]  

  • 20. [Serial angiographic evaluation of the effects of various vasoactive drugs on cerebral circulation in man].
    Bernini FP; Smaltino F
    Acta Neurol (Napoli); 1974 Mar; 29(2):170-84. PubMed ID: 4849693
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.